Clinical Trial Update: Agency in Dystonia [NA]

View source ↗

Summary

Clinical trial NCT03351218 conducted in France by INSERM studying primary dystonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystonia Primary

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Dystonia, Primary | NA | Status: COMPLETED